These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 21442968)

  • 1. [Neurofibromatosis type I--the pediatric endocrinologist's point of view].
    Januś D; Wójcik M; Kalicka-Kasperczyk A; Roztoczyńska D; Wojtyś J; Tyrawa K; Dolezal-Ołtarzewska K; Wcisło B; Was M; Starzyk J
    Przegl Lek; 2010; 67(11):1155-9. PubMed ID: 21442968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical study of neurofibromatosis type 1].
    Lozada Y; Alvarez-Valiente H; Argüelles M
    Rev Neurol; 1998 Nov; 27(159):792-5. PubMed ID: 9859153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Von Recklinghausen neurofibromatosis in Lome, Togo].
    Tchangaï-Walla K; Pitche P; Mijiyawa M; Grunitzky K
    Med Trop (Mars); 1995; 55(2):185-6. PubMed ID: 7565007
    [No Abstract]   [Full Text] [Related]  

  • 4. Neurofibromatosis type 1: update on a common genetic condition.
    Siqveland E; Pond D
    Minn Med; 2009 Mar; 92(3):49-52. PubMed ID: 19400389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neurofibromatosis type 1 complications in the pediatric age: follow-up of a hundred cases].
    Bonnemaison E; Roze-Abert B; Lorette G; Sirinelli D; Boscq M; Mazjoub S; De Courtivron B; Bonnard C; Despert F; Toutain A; Maheut-Lourmière J; Barthez MA; Castelnau P;
    Arch Pediatr; 2006 Jul; 13(7):1009-14. PubMed ID: 16716577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The basics for the diagnosis and management of short stature: a pediatric endocrinologist's approach.
    MacGillivray MH
    Pediatr Ann; 2000 Sep; 29(9):570-5. PubMed ID: 11016050
    [No Abstract]   [Full Text] [Related]  

  • 7. [Neurofibromatosis type 1--own experiences].
    Czajkowski G; Kałuzny J; Jatczak-Gaca A; Wysocki M
    Klin Oczna; 2010; 112(1-3):45-8. PubMed ID: 20572503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of neurofibromatosis type 1 on children's development.
    Haynes NM; Kirwan JR; McCrohan K
    Soc Work Public Health; 2011; 26(4):444-53. PubMed ID: 21707352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eye disorders in neurofibromatosis (NF1).
    Kordić R; Sabol Z; Cerovski B; Katusić D; Jukić T
    Coll Antropol; 2005; 29 Suppl 1():29-31. PubMed ID: 16193672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pediatric otorhinolaryngologic manifestations of endocrinological pathologies.
    Luce FL; Sarandria D; Pozzobon G; Chiumello G; Bussi M
    Int J Pediatr Otorhinolaryngol; 2009 Dec; 73 Suppl 1():S49-55. PubMed ID: 20114156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Structural CNS abnormalities responsible for coincidental occurrence of endocrine disorders, epilepsy and psychoneurologic disorders in children and adolescents].
    Starzyk J; Kwiatkowski S; Kaciński M; Kroczka S; Wójcik M
    Przegl Lek; 2010; 67(11):1120-6. PubMed ID: 21442961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neurofibromatosis type 2 (NF2). Study of 7 patients].
    Pascual-Castroviejo I; Pascual-Pascual SI; Viaño J
    Neurologia; 2009 Sep; 24(7):457-61. PubMed ID: 19921555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Usefulness of systematic brain magnetic resonance imaging in children with neurofibromatosis type 1].
    Blanchard G; Pinson S; Rousselle C; Lorthois S; Combemale P; Bernard M; Lion Francois L
    Arch Pediatr; 2009 Dec; 16(12):1527-32. PubMed ID: 19864117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurofibromatosis type 1 and optic pathway glioma. A long-term follow-up.
    Lama G; Esposito Salsano M; Grassia C; Calabrese E; Grassia MG; Bismuto R; Melone MA; Russo S; Scuotto A
    Minerva Pediatr; 2007 Feb; 59(1):13-21. PubMed ID: 17301720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chiari I malformation and neurofibromatosis type 1.
    Tubbs RS; Rutledge SL; Kosentka A; Bartolucci AA; Oakes WJ
    Pediatr Neurol; 2004 Apr; 30(4):278-80. PubMed ID: 15087107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age at diagnosis of neurofibromatosis 1: an audit of practice.
    Abecassis S; Bastuji-Garin S; Khosrotehrani K; Zeller J; Revuz J; Wolkenstein P
    Dermatology; 2008; 216(4):347-8. PubMed ID: 18277076
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical features and surgical management of orbitotemporal neurofibromatosis: a retrospective interventional case series.
    Altan-Yaycioglu R; Hintschich C
    Orbit; 2010 Oct; 29(5):232-8. PubMed ID: 20812827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neurofibromatosis 1: recommendations for management].
    Pinson S; Créange A; Barbarot S; Stalder JF; Chaix Y; Rodriguez D; Sanson M; Bernheim A; D'incan M; Doz F; Stoll C; Combemale P; Kalifa C; Zeller J; Teillac-Hamel D; Lyonnet S; Zerah M; Lacour JP; Guillot B; Wolkenstein P
    Ann Dermatol Venereol; 2001 Apr; 128(4):567-75. PubMed ID: 11395662
    [No Abstract]   [Full Text] [Related]  

  • 19. [Type 1 neurofibromatosis in Tunisia: 66 cases].
    Gouider R; Azaiz MI; Kchouk M; Lasram L; Ben Osman A; Mrabet A
    Ann Dermatol Venereol; 1994; 121(2):185-9. PubMed ID: 7979037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurofibromatosis type 1 and optic pathway gliomas: follow-up of 54 patients.
    Thiagalingam S; Flaherty M; Billson F; North K
    Ophthalmology; 2004 Mar; 111(3):568-77. PubMed ID: 15019338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.